Right ventricular pacing (RVP) increases risk of atrial fibrillation in patients with implantable cardioverter-defibrillators (ICDs), but ventricular proarrhythmia is less clear. We analyzed a large remote monitoring database to assess this question.
R
ight ventricular pacing (RVP) increases risk of atrial fibrillation, heart failure events, and death in patients with implantable cardioverter-defibrillators (ICDs).
1 RVP may also have ventricular proarrhythmia, but data are scant. Mechanisms may involve pacing-induced ventricular dyssynchrony and short-long-short sequences from competition with intrinsic rhythm or premature ventricular complexes (PVCs). [2] [3] [4] [5] Increasing burden of RVP (%RVP) may constitute a measure of this risk.
Remote monitoring (RM) of patients with networked implantable cardiac devices generates continuously updated databases containing individual device diagnostic data. Therefore, we used the ALTITUDE database of Boston Scientific ICD and cardiac resynchronization therapy defibrillator (CRT-D) devices followed on the LATITUDE RM system to test the hypothesis that if RVP was related to ventricular proarrhythmia, then increasing %RPV would correlate linearly with the risk of appropriate ICD shocks.
METHODS
The design and methods of the ALTITUDE research program to prospectively analyze data from implanted ICD and CRT devices, including expert electrogram adjudication, have been described previously. 6 In brief, beginning in 2006, the ALTITUDE study has been updated with data from the LATITUDE US RM system (Boston Scientific, Marlborough, MA) for clinical research purposes. Uploaded LATITUDE data include device parameters, clinical diagnostics, and episodes which can be leveraged to provide important longitudinal information. Participation in the ALTITUDE initiative is elective and governed by a data use agreement allowing for the use of such deidentified data for research purposes in accordance with Health Insurance Portability and Accountability Act regulations. Only 6% of LATITUDE centers decline to contribute data to ALTITUDE. In this study, patients with networked single-or dualchamber ICDs (excluding biventricular ICDs) were included if they had been engaged in RM for at least 6 months, and tachycardia programming remained unchanged during the study period. A detailed description of the study population, follow-up, and event ascertainment has been previously published.
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WHAT IS KNOWN?
• Right ventricular pacing is associated with an increased risk of various adverse outcomes, including atrial fibrillation, heart failure hospitalizations, and death, in diverse populations.
• The effects of right ventricular pacing on ventricular arrhythmias and implantable cardioverter-defibrillator (ICD) shocks are unclear.
WHAT THE STUDY ADDS?
• Right ventricular pacing was stable over time in ICD recipients, increasing by 1% per year.
• Increasing right ventricular pacing percentage was associated with a trend toward increased risk of appropriate ICD shocks, with a significantly higher risk at 80% to 98%.
• Completely pacing-dependent ICD recipients (≥98%) had a lower risk of appropriate ICD shocks than those with a mixture of pacing and intrinsic ventricular beats.
In each patient, %RVP was calculated each week from RV histogram values received via RM transmission. For weekly transmissions where counters had not been reset since the previous transmission, the difference from the previous transmission for paced and sensed RV beats was calculated, with %RVP determined as the ratio of incremental paced beats to the sum of incremental paced and sensed beats. For weekly transmissions where counters had been reset, %RVP was determined as the ratio of paced to total beats from that transmission. Cumulative %RVP was also calculated at each weekly interrogation based on the sum of estimated incremental paced and sensed beats occurring up to and including that transmission. Relationships between weekly %RVP values between transmissions were investigated using a fixed-effects model. Weekly %RVP values (both incremental and cumulative) were bucketed in the following ranges for analysis: 0% to 1%, 1% to 5%, 5% to 20%, 20% to 40%, 40% to 80%, 80% to 98%, and 98% to 100%. These ranges were selected a priori after review of existing data on %RVP in ICD patients.
Incremental PVC counts were assessed for each weekly transmission in dual-chamber devices and compared across %RVP. Single-or dual-zone programming and lowest programmed zone (≤170, 170-200, or ≥200 beats per minute) were determined as previously described. 7 ICD electrograms preceding the first shock were adjudicated by an expert panel as appropriate or inappropriate, as described previously. 6 Appropriate shocks were correlated with %RVP, both short term in the preceding week and longterm cumulative %RVP.
Cox proportional hazards models predicting appropriate shock incidence were fitted with incremental and cumulative RV pacing by week as time-dependent covariates both individually and as separate covariates. Models were created for single-and dual-chamber devices, as PVC counts are only available in dual-chamber ICDs. The models were adjusted for covariates including age, sex, single-or dual-chamber devices, PVC count (in dual-chamber devices), and tachycardia programming strategy (single or dual zone). Follow-up was censored at first ICD shock (appropriate or inappropriate) or death.
RESULTS
From 8435 patients meeting inclusion criteria (mean age, 64.6±14.1 years; 71.5% male), 425 625 transmissions were received over a mean follow-up of 15.0±8.8 months. %RVP followed a bimodal distribution and was <1% in 59.0% and ≥98% in 5.3% of transmissions ( Figure 1 ). This pattern was observed in both single-and dual-chamber devices. %RVP was stable within individual patients over time, with a mean yearly increase of 0.99%. Lifetime cumulative %RVP was closely correlated with weekly %RVP (R 2 =0.907). In the fixed-effect model, the slope (associated with each collect end date) was 0.0029 supporting the fact that RV pacing remained relatively stable over each transmission. More frequent RVP was associated with increasing age and male sex (Table) . Three hundred eighty-nine patients experienced a first appropriate shock. In the time-dependent Cox proportional hazards model, transmissions with 80% to 98% RVP were associated with a hazard ratio (HR) of 1.56 for an appropriate shock in the subsequent week compared with <1% RVP (95% CI, 1.01-2.41; P=0.04; Figure 2 ). By contrast, ≥98% RVP was associated with a trend toward a lower risk of an appropriate shock (HR, 0.61; 95% CI, 0.33-1.12; P=0.108). Lifetime cumulative %RVP was similarly associated with increased risk of appropriate shocks at 80% to 98% RVP (HR, 1.57 compared with <1% RVP; 95% CI, 1.01-2.44; P=0.046) but not at ≥98% RVP (HR, 0.49; 95% CI, 0.24-1.01; P=0.052; Figure 2 ). This difference was limited to dualchamber devices (HR for >98% RVP versus <1% RVP, 0.48; 95% CI, 0.22-1.04) rather than single-chamber devices (HR, 0.59; 95% CI, 0.08-4.27). Male sex was also associated with the risk of appropriate shock (HR, 1.36; 95% CI, 1.07-1.72; P=0.01). Adjustment for age, sex, programming arm, and PVC counts (in dual-chamber devices) did not significantly change these observed associations (Figures 3 and 4) . 
DISCUSSION
These data show an asymmetrical association of frequent RV pacing with appropriate ICD shocks in a large population of contemporary ICD recipients. We observed an increased risk associated with as little as 20% RVP compared with <1%. This increase continued gradually to the point of 80% to 98% RVP (HR, 2.41 versus <1%). Intriguingly, patients with ≥98% RVP did not experience a further increment in risk of an appropriate shock, but in fact trended toward a lower risk compared with 80% to 98%. We hypothesize that this may be because of a lack of any competition with intrinsic rhythm in this population and therefore a lesser likelihood of pacing-induced short-long-short sequences which can induce ventricular arrhythmias and therefore ICD shocks. 4 It is possible that frequent PVCs reduced the %RVP in some patients who were otherwise pacing dependent, displacing them from ≥98% RVP to 80% to 98% RVP. This effect might have removed patients more likely to receive an ICD shock from this highest %RVP, accounting for the reduced risk of appropriate shock observed. However, adjustment for incremental PVC counts did not change our results, counter to what one might expect with this explanation. These observations were consistent when %RVP was assessed either as a weekly value (the week before the first appropriate shock or the last week of follow-up if no shock) or as a cumulative value (these values were closely correlated). Other covariates which were significantly associated with an increased risk of appropriate shock were male sex and age. The HR for this association was similar in single-and dual-chamber devices; however, the confidence intervals were very wide for single chamber, indicating a large degree of uncertainty and lack of statistical significance. This may reflect the relatively few patients in the higher pacing percentage groups with single-chamber devices, for instance, 9.9% of the 425 patients in the 98% to 100% group, and a resultant lack of statistical power. Patients receiving single-chamber devices may also have different characteristics from those with dualchamber devices, for instance, permanent atrial fibrillation, and it is possible that effects of %RVP are mediated variably in different substrates.
RV pacing is known to increase heart failure hospitalization and death in ICD patients with reduced left ventricular ejection fraction. 1 Mechanisms may include increased left ventricular activation time and depressed contractility. 8, 9 Those with a high proportion of %RVP may be considered for CRT, 10 although a difference in outcome was not observed between CRT-D and ICD (implying frequent RV pacing) in a subgroup analysis of RAFT (Resynchronization-Defibrillation for Ambulatory Heart Failure Trial). 11 A trend toward an increased risk of new-onset atrial fibrillation was seen in the DAVID trial. 1 Ventricular proarrhythmia, and any relationship to %RVP, is unclear. Although post hoc analysis of DAVID found that %RV pacing was associated with the primary end point of death or heart failure hospitalization in a continuous fashion and 40% provided the best separation to predict adverse outcomes, this study did not report ICD shock incidence. 12 An analysis of the MADIT II trial (Multicenter Automatic Defibrillator Implantation Trial) found the risk of appropriate therapy for ventricular arrhythmias increased with %RVP >50% versus <50%.
2 Long-term follow-up of this population confirmed worse outcomes, and attenuation of the benefit of an ICD, in those with >50% RVP, however, could not assess an effect on ICD shocks after the trial period. 13 A post hoc analysis of a subset of patients in the INTRINSIC RV study (Inhibition of Unnecessary RV Pacing With AV Search Hysteresis in ICDs) who were consistently programmed to DDDR mode throughout follow-up identified a complex relationship between RVP and ICD shocks, with 10% to 19% being associated with the lowest risk, and other pacing tiers not having a significantly different risk from >50%, which had the highest number of patients shocked.
14 The smaller numbers in each pacing tier may have limited analysis, however, and only patients consistently programmed DDDR were included, a group that had almost twice the number of appropriate and inappropriate shocks in the study, a so far unexplained finding. 15 Among smaller single-center studies, Smit et al 3 reported that appropriate ICD shocks were more frequent in the >50% paced group (34% versus 21% in ≤50%RVP; P=0.003), and Gardiwal et al 5 found that patients with a cumulative %RVP above the median (2%) had a significantly increased risk of ventricular fibrillation or ventricular tachycardia requiring ICD therapy, which seemed dose dependent across quartiles of %RVP. Both of these populations had largely secondary prevention ICD indications, rendering extrapolation to current ICD patient populations difficult.
The current study benefits from the very large data set, encompassing both single-and dual-chamber devices, in real-world practice. The application of a RM database is particularly useful because it enables longitudinal assessment of device diagnostic data with high granularity and without the dropout associated with overwriting that may occur with programmer-based device interrogations. Our results confirm the finding from both single-center studies 3, 5 and randomized controlled trials 2 that distribution of %RVP is conspicuously bimodal (Figure 1 ). This has limited analytic power in prior trials because relatively few patients fall in the middle of the distribution, but our study contains a relatively large number of patients in this range, permitting assessment of relationship between %RVP and ventricular proarrhythmia with higher resolution. This reveals the important results that risk increases with as little as 20% pacing, which resonates with the recent finding of this figure as a cut point for the development of pacing-induced cardiomyopathy. 16 Notably, >98% RVP (ie, full commitment to ventricular pacing) was associated with less risk of arrhythmia than lesser values suggesting that the mechanism may involve competition from paced and intrinsic rhythms rather than solely pacing-induced electric left ventricular dyssynchrony and depression of left ventricular contractility. 8, 9, 17 Our results also confirm the findings of meta-analysis of randomized trials and a large prospective payor-mandated database that suggest male ICD recipients are at greater risk for appropriate ICD shocks. 18, 19 Limitations of the data set include a lack of demographic and clinical detail, such as ICD indication and left ventricular ejection fraction. Given the large nationwide sample, which, in the other studies, has been matched closely to the National Cardiovascular Data Registry ICD Registry, 20 there is likely a ≈75% prevalence of primary prevention devices. Age, sex, dual-and single-chamber device proportions also mirrored the distribution in the National Cardiovascular Data Registry, suggesting that our study population has broadly similar characteristics. 21 We assessed the association between %RVP and ICD shocks, not within-patient changes in %RVP. Indeed, we found that %RVP is stable over time, and as significant withinpatient changes in %RVP may be because of a wide variety of factors such as drugs, AV node ablation, programming changes, and progression of conduction system disease, individual analysis of each of these situations would be more meaningful. In the ALTITUDE database, the first ICD shock was adjudicated, but not the occurrence or appropriateness of subsequent shocks or of antitachycardia pacing. Therefore, the predictive value of %RVP with respect to antitachycardia pacing, or to VT storm, could not be assessed. However, as even appropriate antitachycardia pacing does not seem to be associated with an increased mortality risk, 22 this may be of limited importance.
CONCLUSIONS
Increasing frequency of RVP, from as little as 20%, is associated with increased risk of appropriate shocks relative to <1% RVP. This suggests a possible ventricular proarrhythmic effect of frequent RVP in ICD patients and further encourages measures to minimize unnecessary RV pacing in ICD recipients. Our findings represent an additional factor to weigh when considering cardiac resynchronization therapy in patients requiring frequent RV pacing. Complete pacing dependence, without competing rhythm or frequent PVCs, may offer some protection against ventricular proarrhythmia.
